全文获取类型
收费全文 | 3628篇 |
免费 | 228篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 108篇 |
妇产科学 | 153篇 |
基础医学 | 507篇 |
口腔科学 | 53篇 |
临床医学 | 372篇 |
内科学 | 762篇 |
皮肤病学 | 72篇 |
神经病学 | 367篇 |
特种医学 | 106篇 |
外科学 | 462篇 |
综合类 | 79篇 |
一般理论 | 1篇 |
预防医学 | 282篇 |
眼科学 | 54篇 |
药学 | 226篇 |
中国医学 | 18篇 |
肿瘤学 | 229篇 |
出版年
2023年 | 20篇 |
2022年 | 29篇 |
2021年 | 69篇 |
2020年 | 45篇 |
2019年 | 50篇 |
2018年 | 72篇 |
2017年 | 56篇 |
2016年 | 66篇 |
2015年 | 70篇 |
2014年 | 102篇 |
2013年 | 128篇 |
2012年 | 189篇 |
2011年 | 251篇 |
2010年 | 132篇 |
2009年 | 111篇 |
2008年 | 197篇 |
2007年 | 228篇 |
2006年 | 209篇 |
2005年 | 225篇 |
2004年 | 173篇 |
2003年 | 193篇 |
2002年 | 172篇 |
2001年 | 77篇 |
2000年 | 90篇 |
1999年 | 89篇 |
1998年 | 50篇 |
1997年 | 47篇 |
1996年 | 28篇 |
1995年 | 44篇 |
1994年 | 32篇 |
1993年 | 30篇 |
1992年 | 73篇 |
1991年 | 51篇 |
1990年 | 51篇 |
1989年 | 36篇 |
1988年 | 49篇 |
1987年 | 32篇 |
1986年 | 17篇 |
1985年 | 31篇 |
1984年 | 19篇 |
1983年 | 16篇 |
1982年 | 13篇 |
1979年 | 16篇 |
1978年 | 13篇 |
1977年 | 13篇 |
1975年 | 10篇 |
1973年 | 17篇 |
1972年 | 14篇 |
1971年 | 14篇 |
1970年 | 18篇 |
排序方式: 共有3869条查询结果,搜索用时 42 毫秒
91.
Sthoeger ZM Fogel M Smirov A Ergas D Lurie Y Bass DD Geltner D Malnick SD 《Annals of the rheumatic diseases》2000,59(6):483-486
OBJECTIVE: Chronic hepatitis C virus (HCV) has been linked to extrahepatic autoimmune phenomena. In addition, a variety of autoantibodies are found in patients with HCV. The prevalence, nature, and clinical significance of anticardiolipin (aCL) autoantibodies in serum samples of patients with HCV were therefore investigated. PATIENTS AND METHODS: A prospective study of 48 consecutive patients with chronic HCV with no evidence of previous hepatitis B virus (HBV) infection or any other autoimmune disorder. Thirty patients with HBV and 50 healthy volunteers matched for age and sex served as control groups. Anticardiolipin antibodies in the serum samples and cryoprecipitates were measured by a sensitive enzyme linked immunosorbent assay (ELISA). The beta(2) glycoprotein I (beta(2)-GPI) dependency was determined by carrying out aCL assays in the presence or absence of fetal calf serum samples. RESULTS: High levels of IgG aCL antibodies were detected in serum samples of 21/48 (44%) patients with HCV. These autoantibodies showed no beta(2)-GPI dependency. The control groups had much lower levels of aCL antibodies (20% in the patients with HBV and none in the normal volunteers). Cryoprecipitates from four patients with HCV (three aCL positive; one aCL negative) were further isolated. In two of the three aCL positive patients, specific cardiolipin reactivity was shown in the cryoprecipitates. The group of patients with HCV and aCL antibodies in their serum showed significantly higher total IgG levels, a higher incidence of antinuclear antibodies, and viraemia (HCV RNA) than the aCL negative patients. None of the patients with HCV and aCL antibodies showed any clinical manifestations related to those autoantibodies. CONCLUSIONS: This study clearly shows a high prevalence of IgG aCL antibodies in the serum of patients with HCV and the localisation of these antibodies in some cryoprecipitates. The role of these autoantibodies on the course of HCV infection and their clinical significance has not yet been determined. 相似文献
92.
93.
94.
Antony W. Burgess Yoav I. Henis Nancy E. Hynes Thomas Jovin Alexander Levitzki Ronit Pinkas-Kramarski 《Growth factors (Chur, Switzerland)》2014,32(2):74-81
AbstractThe epidermal growth factor receptor (EGFR) undergoes a conformational change in response to ligand binding. The ligand-induced changes in cell surface aggregation and mobility have a profound effect on the function of all the family members. Ligand also activates the EGFR intracellular kinase, stimulating proliferation and cell survival. The EGFR family are often activated, overexpressed or mutated in cancer cells and therapeutic drugs (including antibodies) can slow the progress of some cancers. This article provides a brief, annotated summary of the presentations and discussion which occurred at the Epidermal Growth Factor Receptor – Future Directions Conference held in Jerusalem in November 2013. 相似文献
95.
96.
97.
98.
Malik IR Chen A Brass A Ahlén G Rahman M Sällberg M Qureshi JA Frelin L 《Scandinavian journal of infectious diseases》2012,44(1):55-59
A major problem in chronic hepatitis B virus (HBV) infection is that treatment with specific antivirals is life-long since they rarely induce a sustained response. An attractive option is therefore to combine antiviral therapy with some type of immune stimulator, such as a therapeutic vaccine. Several lines of evidence suggest that a key target for the cellular immune response is the HBV core antigen (HBcAg). However, it may also be of advantage to simultaneously improve the neutralizing antibody response to the surface (S) region of HBV. We therefore generated chimeric HBcAg particles expressing preS1 residues 1-42 at the tip of the spike region. We could show that this chimeric HBcAg-preS1 protein primed both HBcAg-specific T cells and antibodies to preS1. This strongly suggests that this may be a viable approach to develop an effective bi-functional therapeutic vaccine as an add-on for the treatment of chronic HBV infections. 相似文献
99.
100.